Slideshow
Here’s a brief look at 6 medications for rheumatologic disorders that were newly approved in the second half of 2018.
CASPAR Criteria May Identify More Patients With Juvenile PsA Than ILAR Criteria
Emerging Agents in the Treatment of Rheumatic Diseases
FDA Accepts New Drug Application for TNX-102 SL in Fibromyalgia
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
Women Who Give Birth After Infertility Have Elevated Risk of Systemic Rheumatic Disease
Patient Education Materials for Rheumatology, Internal Medicine Don’t Meet Readability Standards